PT Kalbe Farma Tbk. PTKFY
8.36 USD 0.00 (+0.00%)
Regular-session close
7.80 Day range 7.80
7.41 52-week range 14.64
- YTD
- -38.11%
- 1 year
- -42.93%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
3.31 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
A+5 / 5 overall
- DCF 5
- Return on Equity 4
- Return on Assets 5
- Debt / Equity 4
- P/E 3
- P/B 4
Valuation
P/E 13.9×
P/S 1.4×
P/B 2.2×
P/FCF 20.8×
EV/EBITDA 8.4×
EV/Sales 1.3×
FCF Yield 4.8%
Profitability
Gross Margin 39.8%
Operating Margin 12.9%
Net Margin 10.4%
ROE 15.7%
ROIC 14.0%
ROA 11.9%
Growth (YoY)
Revenue 8.3%
Operating Income 11.7%
EPS (diluted) 15.3%
Free Cash Flow -30.4%
Financial Health
Current Ratio 3.5×
Quick Ratio 2.2×
Debt / Equity 0.0×
Net Debt / EBITDA -0.7×
Interest Coverage 129×
Dividends
Dividend Yield 3.2%
Payout Ratio 44.6%
Annual · latest fiscal year ends 2025-12-31
